×
FluoroPharma Medical EBITDA 2010-2016 | FPMI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
FluoroPharma Medical ebitda from 2010 to 2016. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
FluoroPharma Medical EBITDA 2010-2016 | FPMI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
FluoroPharma Medical ebitda from 2010 to 2016. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$195.6B
Stryker (SYK)
$137.3B
Boston Scientific (BSX)
$122.7B
Medtronic (MDT)
$114.6B
EssilorLuxottica (ESLOY)
$108.8B
Haleon (HLN)
$48.7B
Lonza Group Ag (LZAGY)
$46B
ResMed (RMD)
$35.1B
Koninklijke Philips (PHG)
$30.8B
Terumo (TRUMY)
$28.5B
Zimmer Biomet Holdings (ZBH)
$22B
Baxter (BAX)
$19.9B
Insulet (PODD)
$16.3B
Smith & Nephew SNATS (SNN)
$13.6B
Bio-Rad Laboratories (BIO)
$9.2B
Demant (WILYY)
$8.7B
BellRing Brands (BRBR)
$7.9B
Lantheus Holdings (LNTH)
$7.5B
ICU Medical (ICUI)
$4.3B
Haemonetics (HAE)
$4.1B
TG Therapeutics (TGTX)
$3.7B
Neogen (NEOG)
$3.6B
Prestige Consumer Healthcare (PBH)
$3.5B
GN Store Nord (GNNDY)
$3.5B
Perrigo (PRGO)
$3.5B
Envista Holdings (NVST)
$3.4B
QuidelOrtho (QDEL)
$3.1B
Agios Pharmaceuticals (AGIO)
$2.6B
Green Thumb Industries (GTBIF)
$2.2B
Maravai LifeSciences Holdings (MRVI)
$2.1B